Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 25, 2017
Optimized expression-based microdissection of formalin-fixed lung cancer tissue
Markus Grafen, Thurid R Hofmann, Andreas H Scheel, et al.
Journal of Cancer Research and Clinical Oncology
|
April 12, 2019
Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva
Fabinshy Thangarajah, Bernd Morgenstern, Caroline Pahmeyer, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 6, 2021
Optimized PD-L1 scoring of gastric cancer
Birgid Schoemig-Markiefka, Jana Eschbach, Andreas H Scheel, et al.
The American Journal of Surgical Pathology
|
July 16, 2013
Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement
Thilo Sprenger, Hilka Rothe, Heinz Becker, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Christoph Arolt, Margaret Dugan, Robert Wild, et al.
NPJ Precision Oncology
|
November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
Christoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Cancers
|
May 14, 2022
High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
Kerstin Menck, Darius Wlochowitz, Astrid Wachter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 9, 2016
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
Andreas H Scheel, Manfred Dietel, Lukas C Heukamp, et al.
NPJ Precision Oncology
|
June 7, 2018
<i>ALK</i><sup>G1269A</sup> mutation as a potential mechanism of acquired resistance to crizotinib in an <i>ALK</i>-rearranged inflammatory myofibroblastic tumor
Sebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.
The Journal of Pathology
|
June 10, 2018
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations
Christina Alidousty, Till Baar, Luciano G Martelotto, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 25, 2017
Optimized expression-based microdissection of formalin-fixed lung cancer tissue
Markus Grafen, Thurid R Hofmann, Andreas H Scheel, et al.
Journal of Cancer Research and Clinical Oncology
|
April 12, 2019
Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva
Fabinshy Thangarajah, Bernd Morgenstern, Caroline Pahmeyer, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 6, 2021
Optimized PD-L1 scoring of gastric cancer
Birgid Schoemig-Markiefka, Jana Eschbach, Andreas H Scheel, et al.
The American Journal of Surgical Pathology
|
July 16, 2013
Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement
Thilo Sprenger, Hilka Rothe, Heinz Becker, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Christoph Arolt, Margaret Dugan, Robert Wild, et al.
NPJ Precision Oncology
|
November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
Christoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Cancers
|
May 14, 2022
High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
Kerstin Menck, Darius Wlochowitz, Astrid Wachter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 9, 2016
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
Andreas H Scheel, Manfred Dietel, Lukas C Heukamp, et al.
NPJ Precision Oncology
|
June 7, 2018
<i>ALK</i><sup>G1269A</sup> mutation as a potential mechanism of acquired resistance to crizotinib in an <i>ALK</i>-rearranged inflammatory myofibroblastic tumor
Sebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.
The Journal of Pathology
|
June 10, 2018
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations
Christina Alidousty, Till Baar, Luciano G Martelotto, et al.
Page
of 5